Πέμπτη 5 Ιανουαρίου 2017

Gene test could pinpoint patients sensitive to new type of cancer drug

Testing for a gene commonly mutated in ovarian cancers could pick out patients who will respond well to a promising new class of cancer drugs, a major new study reveals. Scientists found that defects in a gene called ARID1A caused sensitivity to new...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jd2YmL
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις